HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pingshuan Dong Selected Research

Acute Coronary Syndrome

1/2020Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis.
1/2016Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients - a single center prospective randomized controlled study in a Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pingshuan Dong Research Topics

Disease

9Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 01/2014
5Essential Hypertension
01/2022 - 04/2014
4Thrombosis (Thrombus)
08/2014 - 10/2013
3Hypertension (High Blood Pressure)
01/2021 - 01/2015
3Myocardial Infarction
05/2014 - 06/2013
2Reperfusion Injury
09/2021 - 02/2018
2Type 2 Diabetes Mellitus (MODY)
07/2020 - 01/2019
2Body Weight (Weight, Body)
07/2020 - 01/2019
2Acute Coronary Syndrome
01/2020 - 01/2016
2ST Elevation Myocardial Infarction
06/2014 - 06/2013
1Ischemia
09/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
09/2021
1Hypoxia (Hypoxemia)
09/2021
1Wounds and Injuries (Trauma)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Weight Loss (Weight Reduction)
07/2020
1Cardiotoxicity
06/2020
1Heart Diseases (Heart Disease)
06/2020
1Death (Near-Death Experience)
01/2016
1Heart Failure
01/2016
1Anemia
01/2016
1Myxoma (Myxomas)
05/2015
1Atrial Fibrillation
12/2014
1Cardiovascular Diseases (Cardiovascular Disease)
06/2013

Drug/Important Bio-Agent (IBA)

3Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 01/2019
2Angiotensin Receptor AntagonistsIBA
01/2021 - 01/2019
2Hypoglycemic Agents (Hypoglycemics)IBA
07/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
06/2020 - 05/2015
2EverolimusFDA Link
06/2014 - 05/2014
1salicylhydroxamic acid (SHAM)IBA
01/2022
1Long Noncoding RNAIBA
09/2021
1puerarinIBA
09/2021
1NF-kappa B (NF-kB)IBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1NADP (NADPH)IBA
01/2021
1LiraglutideFDA Link
07/2020
1Biological ProductsIBA
06/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2020
1HydrogelsIBA
06/2020
1Sericins (Sericin)IBA
06/2020
1ferric oxide (iron oxide)IBA
06/2020
1olmesartanIBA
05/2019
1azilsartanIBA
05/2019
1Untranslated RNA (Noncoding RNA)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1LipidsIBA
01/2019
1Hemoglobins (Hemoglobin)IBA
01/2019
1candesartanIBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1Uric Acid (Urate)IBA
01/2019
1empagliflozinIBA
01/2019
1Telmisartan (Micardis)FDA Link
01/2019
1fasudil (AT 877)IBA
02/2018
1Prasugrel HydrochlorideFDA Link
11/2017
1TicagrelorIBA
11/2017
1Cystatin CIBA
08/2017
1Spironolactone (Aldactone)FDA LinkGeneric
04/2017
1HematinicsIBA
01/2016
1omega-Chloroacetophenone (Mace)IBA
01/2016
1MEF2 Transcription FactorsIBA
05/2015
1Messenger RNA (mRNA)IBA
05/2015
13' Untranslated Regions (3' UTR)IBA
05/2015
1AldehydesIBA
01/2015
1ThrombomodulinIBA
01/2015
1Aldehyde DehydrogenaseIBA
01/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2014
1PolymersIBA
08/2014
1Pharmaceutical PreparationsIBA
06/2014
1MetalsIBA
06/2014
1Paclitaxel (Taxol)FDA LinkGeneric
05/2014
1Sirolimus (Rapamycin)FDA Link
05/2014
1zotarolimusIBA
05/2014
1Met Transfer RNAIBA
04/2014
1Plasminogen Activators (Plasminogen Activator)IBA
01/2014
1Plasminogen Activator Inhibitor 1IBA
01/2014
1Tirofiban (Aggrastat)FDA Link
10/2013
1Thymidine Monophosphate (TMP)IBA
10/2013

Therapy/Procedure

5Therapeutics
01/2022 - 12/2014
4Percutaneous Coronary Intervention
01/2020 - 06/2013
3Drug-Eluting Stents
08/2014 - 05/2014
3Stents
08/2014 - 05/2014
1Catheters
01/2022
1Denervation
01/2022
1Chronotherapy
01/2021
1Glycemic Control
01/2015
1Electric Countershock (Cardioversion)
12/2014
1Counterpulsation (External Counterpulsation)
06/2013